Sign In
Buy TWST
$72.33
+2.18 (+3.11%)
At Close: Jun 03, 2026
Twist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population Genomics
08:00am, Wednesday, 30'th Oct 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon
Twist Bioscience to Present at Baird Global Healthcare Conference 2024
08:00am, Tuesday, 27'th Aug 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon
3 Healthcare AI Stocks Positioned for Potential Breakthroughs
06:47am, Wednesday, 07'th Aug 2024
Markets tanked on Monday because the Japanese central bank raised its interest rate to 0.25%. Interest rates were originally at a benchmark between 0 and 0.1, meaning a minor 15- to 25-basis-point inc
The 3 Best Med Tech Stocks to Buy Now
11:20am, Monday, 05'th Aug 2024
According to the Advanced Medical Technology Association, med tech is defined as “companies that develop, manufacture, and distribute the technologies, devices, equipment, diagnostic tests, and heal
Twist Bioscience: Lowered Biopharma Expectations Amid Financial Strain (Rating Downgrade)
08:50am, Sunday, 04'th Aug 2024
Twist Bioscience reported revenue of $81.5 million in Q2 (fiscal Q3), marking a 28% increase from Q2, 2023. Twist's biopharma segment underperformed, contributing to a significant impairment charge. T
Twist Bioscience Corporation (TWST) Q3 2024 Earnings Call Transcript
02:37pm, Friday, 02'nd Aug 2024
Twist Bioscience Corporation (NASDAQ:TWST ) Q3 2024 Earnings Conference Call August 2, 2024 8:00 AM ET Company Participants Angela Bitting - Senior Vice President, Corporate Affairs Emily Leproust - C
Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates
09:40am, Friday, 02'nd Aug 2024
Twist Bioscience (TWST) came out with a quarterly loss of $0.86 per share versus the Zacks Consensus Estimate of a loss of $0.79. This compares to loss of $1.01 per share a year ago.
Twist Bioscience Reports Fiscal Third Quarter 2024 Financial Results
07:30am, Friday, 02'nd Aug 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
09:50am, Tuesday, 30'th Jul 2024
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Twist Bioscience (TWST) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
11:05am, Friday, 26'th Jul 2024
Twist Bioscience (TWST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
09:50am, Monday, 22'nd Jul 2024
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Take the Zacks Approach to Beat the Markets: NVIDIA, Twist Bioscience, Ollie's Bargain Outlet in Focus
09:57am, Monday, 15'th Jul 2024
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Twist Bioscience to Report Fiscal 2024 Third Quarter Financial Results on Friday, August 2, 2024
08:00am, Thursday, 11'th Jul 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon
Twist Bioscience Publishes Preclinical Data Detailing Discovery of Antibody Targeting Emerging Checkpoint Inhibitor
08:00am, Thursday, 06'th Jun 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon
Twist Bioscience Announces Participation in Department of Commerce Consortium Dedicated to AI Safety
08:00am, Tuesday, 04'th Jun 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon
